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Objective: Predictors of late conversion to conventional surgery after thoracic endo-
vascular stent-graft placement are currently unknown.
Methods: We analyzed data from 422 of 457 consecutive patients who underwent en-
dovascular thoracic repair with the Medtronic Talent thoracic stent-graft (Medtronic/
AVE, Santa Rosa, Calif). Of these, 16 patients (3.8%) required late conversion to open
surgery during a median follow-up interval of 17 months (range 7–33 months). Six of
these patients had undergone previous aortic surgery, 3 patients had previous cardiac
surgery, and 5 patients had Marfan syndrome. In patients with late conversion, indi-
cations for primary stent-graft placement were dissection in 10 patients, degenerative
aneurysm in 5 patients, and penetrating ulcer in 1 patient.
Results: By multivariable Cox analysis, Marfan syndrome (adjusted hazard ratio 9.97,
P5 .008), type I endoleak (adjusted hazard ratio 3.99, P5 .012), the use of more than
1 stent-graft (adjusted hazard ratio 3.89, P5 .018), and procedural complications (ad-
justed hazard ratio 17.50, P 5 .003) were independent predictors of late conversion.
Conclusion: Endovascular treatment for thoracic aortic disease with the Talent stent-
graft is associated with a relatively low rate of late conversion to conventional surgery.
Better results may be achieved by excluding patients with Marfan syndrome for such
a procedure and early aggressive treatment of early type I endoleaks.
D
escending thoracic aortic aneurysms still represent a potentially life-threaten-
ing situation and occur exclusively in this portion of the aorta in 20% to 30%
of all aneurysm cases.1,2 Conventional resection and graft replacement of
descending thoracic aortic aneurysms has been the preferred method of treatment
but is associated with high morbidity and mortality rates despite improved surgical
techniques, intraoperative monitoring of somatosensory-evoked potentials, and spinal
fluid drainage.3-6 The patient population are usually of older age and present at the
time of operation with various comorbidities such as hypertension, obstructive pulmo-
nary disease, and coronary heart disease, all of which have a significant impact on the
surgical outcome. Postoperative complications, such as paraplegia and renal and pul-
monary insufficiency, contribute to prolonged hospital stays and higher medical cost.
Since the first endovascular stent-graft (ESG) experience in an abdominal aortic
aneurysm,7 various groups have started to investigate the feasibility of thoracic aortic
aneurysmal repair with ESGs.8,9 During the last decade, endovascular techniques
From the Department of Cardiothoracic Sur-
gery, University of Vienna,a Vienna, Aus-
tria; Department of Cardiology, University
Hospital Rostock,b Rostock, Germany; De-
partment of Radiology, Centre Hospitalier
Universitaire, Hopital de Rangueil,c Tou-
louse, France; Radiologie Vasculaire, Hopi-
tal Cardiologique CHRU de Lille,d Lille,
France; Centre Hospitalier Universitaire,
Hopital Sainte Marguerite,e Marseille,
France; Department of Cardiothoracic Sur-
gery, St Antonius Hospital,f Nieuwagein,
The Netherlands; Centre Hospitalier Univer-
sitaire, Hopital de la Timone,g Marseille,
France; Department of Internal Medicine,
University of Vienna,h Austria; and Cardio-
vascular Radiology, University Hospital S.
Orsola,i Bologna, Italy.
This is a company registry study of the Med-
tronic Talent thoracic stent-graft. Jean-Paul
Beregi reports consulting fees from Cordis
and Medtronic, and lecture fees from EV3,
Boston Scientific, and Medtronic. Christoph
Nienaber reports consulting and lecture fees
from Medtronic, Boston Scientific, and Cor-
dis. Rosella Fattori reports consulting fees
from Medtronic. Herve Rousseau reports
consulting and lecture fees from Medtronic
and Gore.
Received for publication May 28, 2007;
revisions received Sept 2, 2007; accepted
for publication Sept 12, 2007.
Address for reprints: Rossella Fattori, MD,
Department of Radiology-Cardiovascular
Unit, University Hospital S. Orsola, Via
Masseranti 9, 40128 Bologna, Italy
(E-mail: rosella.fattori@unibo.it).
J Thorac Cardiovasc Surg 2008;135:1322-6
0022-5223/$34.00
Copyright  2008 by The American Asso-
ciation for Thoracic Surgery
doi:10.1016/j.jtcvs.2007.09.036
1322 The Journal of Thoracic and Cardiovascular Surgery c June 2008
Ehrlich et al Evolving Technology
ETAbbreviation and Acronym
ESG 5 endovascular stent-graft
have revolutionized the management of descending thoracic
aortic disease, with the benefit of exclusion of the patholog-
ically altered aorta without direct surgical exposure. Al-
though an endovascular technique was initially reserved for
patients not suitable for conventional surgery, clinical suc-
cess led to rapid expansion of indications.10,11 Nevertheless,
both the potential risk of device failure and the concern about
long-term durability remain unresolved issues with this
emerging treatment modality. The Talent Thoracic Registry
was designed to collect outcome data from patients who
underwent endoluminal treatment with the Medtronic Talent
thoracic stent-graft (Medtronic/AVE, Santa Rosa, Calif) in
7 European referral centers, and short-term results were
reported.12 For this article, data collection and analysis
were particularly focused on predictors of late conversion
to open surgery after thoracic ESG placement.
Materials and Methods
Enrollment
The entire cohort study consisted of 457 consecutive patients who
underwent endovascular thoracic aortic repair with the Talent tho-
racic stent-graft between November of 1996 and March of 2004.
Seven European referral centers (Bologna, Toulouse, Rostock, Lille,
Vienna, Nieuwegein, and Marseille) provided data from patients
treated consecutively, with a minimum of 1-month follow-up. The
ethical committee of each institute approved the study. Follow-up
analysis was formed on clinical and imaging findings until the last
visit date, including all adverse events. Data were collected on
case report forms and entered in 2 separate databases by a data-col-
lection specialist and the lead author (R. F.; Maastricht, The Nether-
lands, and Bologna, Italy). Case report forms were all reviewed by
the lead author and checked for inconsistencies. In case of discrep-
ancies, the relevant investigator was queried to ensure appropriate
interpretation of events. The 2 different databases were then com-
pared, and errors in data entries were corrected by cross-checking
on the specific case report form.
Device Description
The Talent thoracic stent-graft is composed of Dacron graft fabric
supported by self-expanding nitinol springs. The springs are sewn
to the graft material with polyester sutures. The graft material is
a sheet of monofilament polyester with a seam joining the edges
to create a cylindric tube. The connecting bar provides columnar
strength to the device and facilitates deployment. All nitinol compo-
nents are surface treated to enhance long-term fatigue performance.
The Talent stent-graft system has many modular sections that can be
used to treat a wide variety of thoracic lesions. The stent-graft has 3
proximal and distal configurations. The proximal configurations are
FreeFlo, Bare Spring (22 mm only), and Open Web, all of which all
have a flared geometry. The FreeFlo design (different from the Bare
Spring configuration) has a bare spring and a mini-support spring,The Journal of Thoracwhich improves sealing for sizes 24 to 46 mm. The distal configu-
rations are Bare Spring, Closed Web, and Open Web. The Open
Web configuration was designed for use as distal extensions for
the Talent stent-graft system.
Indication for Operation
The indication for conventional surgery after primary stent-graft
placement in these 16 patients was a progressive expansion of the
aneurysm in 14 cases and impending rupture in 2 patients.
Operative Technique
The operative technique was selected according to the localization
of the secondary pathology from either endoleaks or other causes
in the distal arch or descending aorta. Patients underwent operation
by arch replacement via a median sternotomy or distal arch and de-
scending thoracic aorta replacement via a left thoracotomy. Either
deep hypothermic circulatory arrest or left heart bypass technique
was used.5,13 Patients who required deep hypothermic circulatory
arrest were cooled to 18C, and circulatory arrest was initiated.
One patient who experienced an acute retrograde type A dissection
6 months after ESG placement for primary acute type B dissection
underwent ascending aorta and a frozen elephant trunk repair
through a median sternotomy.14 In this patients, antegrade cerebral
perfusion was used as an additional brain protection technique. In all
16 patients, the aneurysmal sac was longitudinally opened and any
stent-grafts were harvested. Intercostal arteries were not reimplanted
in any of the 16 patients. The aneurysm was replaced by a Dacron
prosthesis.
Statistical Analysis
Continuous data are reported as the mean 6 standard deviation or
median and total range. Univariate comparisons were done by chi-
square tests or Mann–Whitney U tests, as appropriate. Estimates
of times to events and the accompanying curves were generated
by the method of Kaplan–Meier. Multivariable Cox proportional
hazards analysis was applied to determine independent predictors
of late conversion adjusting for potential confounders. Baseline var-
iables that were imbalances between patients with and without late
conversion by a P value less than .05 were entered into the models.
The results of the Cox models are reported as hazard ratios and 95%
confidence intervals. We tested for interactions between baseline
variables by multiplicative interaction terms and log likelihood
chi-square tests. We assessed the overall model fit using Cox–Snell
residuals. Furthermore, we tested the proportional hazard assump-
tion for all covariates using Schoenfeld residuals (overall test) and
the scaled Schoenfeld residuals (variable-by-variable testing). Ac-
cording to the tests, the proportional hazards assumption was not
violated. Statistical analysis was carried out with SPSS software
package version 13.0 (SPSS, Inc, Chicago, Ill).
Results
Thirty-six of the 457 patients (7.9%) died within 30 days of
the primary stent-graft procedure or within the same hospital-
ization. Eleven of the deaths were related to the aorta, and
the remaining 25 deaths were attributable to other causes,
leaving 422 patients (92.3%) for this final analysis. A total
of 403 of the 422 patients (95%) had a 3-month follow-up,ic and Cardiovascular Surgery c Volume 135, Number 6 1323
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the median follow-up time of 17 months (interquartile range
7–33 months), 16 of 421 patients (3.8%) required late con-
version to open surgery after a median interval of 14 months
(interquartile range 5–42 months). Baseline demographic and
clinical characteristics of patients with and without late
conversion are listed in Table 1.
Indication for late conversion to open surgery was the
presence of endoleaks in 15 patients (7 early, 8 late endo-
leaks) and a retrograde type A dissection in 1 patient. Univar-
iate predictors for late conversion were previous cardiac
surgery (P 5 .010), maximal aortic diameter (P 5 .010),
Marfan syndrome (P , .001), early type I endoleak (P 5
.003), and use of more than 1 stent-graft (P5 .016). Dissec-
tion and acute operation showed a borderline significance
(P 5 .062 and P 5 .094).
Procedural characteristics of the initial stent-graft implan-
tation are listed in Table 2. Patients who underwent late con-
version had a larger maximal aortic aneurysmal diameter at
the time of the primary stent-graft placement (77 mm vs 54
mm; P 5 .01), and several patients in this group needed
more than 3 stent-grafts to cover the aneurysmal sac (P 5
.01). Furthermore, the presence of early endoleak was signif-
icantly higher in the late conversion group (43.8% vs 15.8%;
P 5 .003).
All but 1 patient survived the complex surgical repair
without major complications, resulting in a hospital mortality
rate of 6.2%. Fifteen patients underwent operation via a left
thoracotomy, and 1 patient required a median sternotomy.
Eleven of the 16 patients (69%) underwent operation in
deep hypothermic circulatory arrest, and the mean circulatory
arrest time in this patient group was 39 minutes. One patient
required total arch replacement, and 4 patients required
partial arch replacement. No neurologic complications were
encountered.
By multivariable Cox analysis, Marfan syndrome (ad-
justed hazard ratio 9.97, P5 .008), type I endoleak (adjusted
hazard ratio 3.99, P 5 .012), the use of more than 1 stent-
graft (adjusted hazard ratio 3.89, P 5 .018), and procedural
complications (adjusted hazard ratio 17.50, P 5 .003) were
independent predictors of late conversion. The variables
age, gender, previous cardiac surgery, maximal aortic diam-
eter, acute operation, and aortic dissection showed no signif-
icant association with late conversion (Table 3).
Discussion
This is the first article to report on the late conversion rate to
conventional surgery after thoracic ESG placement with the
Talent stent-graft. Of the 422 consecutive patients who un-
derwent endovascular thoracic repair and were not lost to fol-
low-up, 16 (3.8%) required late conversion to open surgery
after a median interval of 14 months. This rate is much lower
than for conversion of abdominal aortic aneurysms as re-
cently reported, with a late conversion rate of 7.9%.15 As1324 The Journal of Thoracic and Cardiovascular Surgery c Juin our study, the indication for late conversion was a persis-
tent endoleak.
Transluminal placement of ESGs has been used to treat
abdominal aortic aneurysms and descending thoracic aortic
pathologies.8 Stent-graft repair of the descending thoracic
aorta seems to offer a feasible and safe alternative
TABLE 1. Baseline demographic data and clinical
characteristics of patients with and without late
conversion after endovascular treatment of descending
thoracic aorta aneurysms
Patients without
late conversion
(n 5 406, 96.2%)
Patients with
late conversion
(n 5 16, 3.8%)
P
value
Male gender (%) 309 (76.1%) 15 (93.8%) .10
Age (y) 59 (16) 55 (17) .20
ASA score .51
ASA 24 (5.9%) —
ASA 1 37 (9.1%) 1 (6.3%)
ASA 2 125 (3088%) 3 (18.8%)
ASA 3 164 (40.4%) 9 (56.3%)
ASA 4 43 (10.6%) 3 (18.8%)
ASA 5 13 (3.2%) —
Smoking (SVS score) .35
0 190 (53.q%) 10 (66.7%)
1 80 (22.2%) 1 (6.7%)
2 70 (19.4%) 4 (26.7%)
3 19 (5.3%) —
Cardiac comorbidity (SVS
score)
.051
0 2980 (72.4%) 9 (56.3%)
1 61 (15.08%) 5 (31.3%)
2 43 (11.1%) 1 (6.3%)
3 3 (0.88%) 1 (6.3%)
Pulmonary comorbidity
(SVS score)
.92
0 3600 (76.9%) 12 (75.0%)
1 55 (14.1%) 3 (18.8%)
2 29 (7.4%) 1 (6.3%)
3 6 (1.5%) —
Previous aortic
surgery (%)
89 (21.9%) 6 (37.5%) .14
Previous cardiac
surgery (%)
18 (4.4%) 3 (18.8%) .010
Aneurysm (%) 129 (31.8%) 5 (31.3%) .97
Dissection (%) 159 (41.7%) 10 (62.5%) .062
acute 33 (8.1%) 2 (12.5%)
chronic 126 (31%) 8 (50%)
Penetrating ulcer (%) 27 (6.7%) 1 (6.3%) .95
Intramural hematoma (%) 13 (3.2%) — .47
Traumatic aortic
injury (%)
87 (21.4%) — .038
Marfan syndrome (%) 10 (2.5%) 5 (31.3%) ,.001
Acute operation (%) 99 (24.4%) 1 (6.3%) .094
ASA, American Surgical Association; SVS, Society for Vascular Surgery.ne 2008
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term follow-up is limited, clinical results have been prom-
ising.12 Stent-graft placement may be of particular benefit,
especially in high-risk patients, because this new procedure
is easier and less invasive than the conventional surgical
approach.19 We and others have shown that this method
for treating thoracic aortic disease is associated with low
early morbidity and mortality rates for patients at high
risk and treated on an emergency base, as well as a
good long-term outcome.12
In addition to the low incidence of late conversions, the
morbidity and mortality rate associated with this late conver-
sion to conventional surgery was much lower than other in-
vestigators have found in abdominal aneurysms.20,21 Only
1 of the 16 patients died after the procedure. The other 15 pa-
tients experienced no major postoperative complication and
had an uneventful recovery.
By multivariable Cox analysis, Marfan syndrome, proce-
dural complications, type I endoleak, and the use of more
than 1 stent-graft were significant predictors of late conver-
TABLE 2. Procedural and postprocedural characteristics
of patients with and without late conversion after
endovascular treatment of descending aortic aneurysms
Patients without
late conversion
(n 5 406, 96.2%)
Patients with
late conversion
(n 5 16, 3.8%)
P
value
No. of stent-grafts implanted .016
1 289 (71.2%) 8 (50.0%)
2 87 (21.4%) 3 (18.8%)
3 26 (6.5%) 5 (31.3%)
4 2 (0.5%) —
5 1 (0.2%) —
6 1 (0.2%) —
Maximal aortic
diameter (mm)
54 (20) 77 (6) .010
Length of the aortic
neck (mm)
36 (34) 46 (54) .97
Cumulative length
of stent-grafts (%)
126 (46) 155 (67) .14
Occlusion of the
subclavian artery (%)
49 (12.1%) 2 (12.5%) .96
Early endoleak (%) 78 (19.2%) 7 (43.8%) .016
Type 1 64 (15.8%) 7 (43.8%) .003
Type 2 4 (1%) — .69
Type 3 5 (1.2%) — .66
Type 4 2 (0.5%) — .78
Type 5 2 (0.5%) — .78
Procedural complications (%) 8 (2%) 2 (12.5%) .007
Immediate conversion (%) 3 (0.7%) — .73
Early reintervention (%) 8 (2.0%) 1 (6.3%) .25
Major complications (%) 32 (7.9%) 1 (6.3%) .81
Intraoperative death (%) — — —
Additional procedure (%) 22 (5.4%) 1 (6.3%) .89The Journal of Thorsion. Procedural complications occurred in 2 patients: The
dissection extended into the proximal aorta after stent-graft
placement in 1 patient, and the stent-graft dislocated on
deployment in 1 patient. Both patients underwent operation
conventionally 5 and 6 weeks after the primary procedure.
The occurrence of late endoleak formation requiring elective
surgical reintervention after stent-graft placement was ac-
ceptably low in this study (1.9%). It was primarily observed
after ESG for aortic type B dissection (62.5%). Late type I en-
doleaks resulting from chronic enlargement of the proximal
or distal landing zone developed in 3 patients. In addition
to the progression of the underlying atherosclerotic disease,
short proximal or distal landing zones were causative for
treatment failure. One of our patients with a type I endoleak
exhibited a proximal landing zone of less than 20 mm in
length, although a subclavian to carotid artery transposition
was performed before the ESG. The remainder with type Ib
endoleaks showed a critical distal landing zone at the time
of implantation, which was characterized by partial thrombus
formation at the aortic wall and a critical diameter of 38 mm.
The risk of retrograde aortic dissection after ESG has been
reported.14 We observed this fatal complication in 1 patient.
Injury of the intima by the bare springs of the Talent stent-
graft device is suspected to be the cause of this complication.
Although this stent-graft–related complication is rare and oc-
curred in only 1 patient in this large series, the development
of specially designed stent-grafts for aortic dissection is war-
ranted. The expansion of stent-grafts in the friable tissue of an
acute dissected aorta is different than the deployment of ESG
in chronic atherosclerotic aneurysms. In atherosclerotic aneu-
rysms, the anchorage of the ESG is dependent on a relatively
short proximal and distal landing zone, which necessitates
high radial forces generated by the stent. In contrast, ESGs
for the treatment of acute dissections have to be designed dif-
ferently with respect to radial force and flexibility. Because
the entire length of the ESG is in contact with the aortic
wall, less radial force is sufficient to ensure proper fixation
TABLE 3. Cox proportional hazards model assessing the
risk for late conversion in patients undergoing
endovascular repair of descending aortic disease
Hazard ratio 95% CI P value
Age (y) 1.00 0.96–1.04 .93
Male gender 4.25 0.55–32.8 .17
Previous cardiac surgery 1.18 0.22–6.28 .85
Dissection 1.69 0.48–5.96 .41
Marfan syndrome 9.97 1.84–54.04 .008
Emergency surgery 4.78 0.35–65.30 .24
Maximal aortic diameter 1.03 0.98–1.08 .31
Type 1 endoleak 3.99 1.35–11.76 .012
Use of . 1 stent-graft 3.89 1.26–12.04 .018
Procedural complications 17.50 2.70–113.40 .003
CI, Confidence interval.acic and Cardiovascular Surgery c Volume 135, Number 6 1325
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reduce the risk for subsequent injury of adjacent aortic tissue.
Most important, the incidence of late conversion after
stent-graft placement was significantly high in patients with
Marfan syndrome. Five of the 16 patients (31.3%) who re-
quired late open surgery had this connective tissue disease.
In light of this remarkable finding, patients with Marfan syn-
drome should not be treated with endovascular stent-grafts
because of their thin, weak, and friable aortic wall that will
predispose them to further developing false aneurysm or
endoleaks.
Although impressive results and amazing developments
have been achieved since the first introduction of ESG in
1991, this technology is still in its infancy. The potential
risk of device failure and the concern about long-term dura-
bility constitute the major unresolved issues in this emerging
treatment modality. Emphasis should be placed on appropri-
ate case selection and the stringency of lifelong surveillance
after endovascular therapy, which will further elucidate the
indications and limitations of this innovative therapy.
Conclusions
Endovascular graft repair is not as durable as open repair.
However, the rate of late conversion to open surgery was
relatively small in this larger series with high success rates.
Patients need to be informed of the need for lifelong surveil-
lance and the possible need for secondary procedures before
ESG treatment. For patients with Marfan syndrome, EVG
repair should currently be performed with extreme caution
and restraint.
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